Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2751
Repay Holdings
RPAY
$311M
| $2.5M | ﹤0.01% |
684,954
-472,383
| -41% | -$1.89M |
|
2752
Universal Insurance Holdings
UVE
$1.18B
| $2.5M | ﹤0.01% |
73,876
+1,090
| +1% | +$34.8K |
|
2753
CALL
TMC The Metals Company
TMC
$1.91B
| $2.49M | ﹤0.01% |
+404,300
| New | +$2.84M |
|
2754
Alkami Technology
ALKT
$2.16B
| $2.48M | ﹤0.01% |
107,487
+6,462
| +6% | +$143K |
|
2755
First Financial Corp
THFF
$970M
| $2.47M | ﹤0.01% |
40,900
+3,712
| +10% | +$214K |
|
2756
Alamos Gold
AGI
$13.8B
| $2.46M | ﹤0.01% |
63,740
-94,652
| -60% | -$3.3M |
|
|
DFTX
2757
Definium Therapeutics
DFTX
$5.9B
| $2.46M | ﹤0.01% |
183,623
+33,018
| +22% | +$409K |
|
2758
TriCo Bancshares
TCBK
$1.84B
| $2.46M | ﹤0.01% |
51,860
+7,965
| +18% | +$366K |
|
2759
Live Oak Bancshares
LOB
$1.98B
| $2.45M | ﹤0.01% |
71,380
+16,895
| +31% | +$566K |
|
|
GLXY
2760
Galaxy Digital Inc
GLXY
$4.07B
| $2.45M | ﹤0.01% |
109,632
+6,746
| +7% | +$209K |
|
2761
MarineMax
HZO
$1.15B
| $2.45M | ﹤0.01% |
101,051
+2,560
| +3% | +$63.2K |
|
2762
Dillards
DDS
$9.93B
| $2.44M | ﹤0.01% |
4,031
+2,473
| +159% | +$1.56M |
|
2763
Payoneer
PAYO
$2.41B
| $2.44M | ﹤0.01% |
434,653
+24,803
| +6% | +$143K |
|
|
AAUC
2764
Allied Gold Corp
AAUC
$3.14B
| $2.44M | ﹤0.01% |
+106,738
| New | +$2.06M |
|
|
AAT
2765
American Assets Trust
AAT
$1.39B
| $2.44M | ﹤0.01% |
128,851
+14,693
| +13% | +$284K |
|
2766
Helen of Troy
HELE
$696M
| $2.43M | ﹤0.01% |
114,549
+81,874
| +251% | +$1.67M |
|
2767
Lindsay Corp
LNN
$1.18B
| $2.43M | ﹤0.01% |
20,647
+2,211
| +12% | +$266K |
|
2768
Compañía de Minas Buenaventura
BVN
$8.79B
| $2.43M | ﹤0.01% |
87,327
-27,397
| -24% | -$684K |
|
2769
Interparfums
IPAR
$3.78B
| $2.43M | ﹤0.01% |
28,608
+2,294
| +9% | +$202K |
|
2770
Standard Motor Products
SMP
$877M
| $2.43M | ﹤0.01% |
65,850
+5,104
| +8% | +$196K |
|
2771
CALL
Sarepta Therapeutics
SRPT
$1.94B
| $2.42M | ﹤0.01% |
112,300
-165,000
| -60% | -$3.48M |
|
|
SKE
2772
Skeena Resources
SKE
$4.12B
| $2.41M | ﹤0.01% |
101,729
-43,803
| -30% | -$864K |
|
2773
CRA International
CRAI
$1.07B
| $2.41M | ﹤0.01% |
12,024
+439
| +4% | +$82.7K |
|
2774
LGI Homes
LGIH
$1.32B
| $2.41M | ﹤0.01% |
56,045
+13,143
| +31% | +$616K |
|
2775
CALL
EOG Resources
EOG
$75.1B
| $2.4M | ﹤0.01% |
22,900
| – | – |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.